These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10837846)

  • 1. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?
    Balfour DJ; Ridley DL
    Pharmacol Biochem Behav; 2000 May; 66(1):79-85. PubMed ID: 10837846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuronal pathways mediating the behavioral and addictive properties of nicotine.
    Balfour DJ
    Handb Exp Pharmacol; 2009; (192):209-33. PubMed ID: 19184651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological aspects of the link between smoking and depression.
    Quattrocki E; Baird A; Yurgelun-Todd D
    Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence.
    Balfour DJ; Wright AE; Benwell ME; Birrell CE
    Behav Brain Res; 2000 Aug; 113(1-2):73-83. PubMed ID: 10942034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
    Chiamulera C; Marzo CM; Balfour DJK
    Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Empirical basis for breaking the tobacco smoking habit].
    Starek A
    Przegl Lek; 2001; 58(4):220-2. PubMed ID: 11450338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.
    Besson M; Guiducci S; Granon S; Guilloux JP; Guiard B; Repérant C; Faure P; Pons S; Cannazza G; Zoli M; Gardier AM; Maskos U
    Psychopharmacology (Berl); 2016 Sep; 233(18):3297-314. PubMed ID: 27385416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of stress on psychopharmacological responses to nicotine.
    Balfour DJ
    Br J Addict; 1991 May; 86(5):489-93. PubMed ID: 1859910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nicotine as an antidepressant and regulator of sleep in subjects with depression].
    Vieyra-Reyes P; Venebra-Muñoz A; Rivas-Santiago B; García-García F
    Rev Neurol; 2009 Dec 16-31; 49(12):661-7. PubMed ID: 20013719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
    Le Houezec J
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopamine in the behavioural actions of nicotine related to addiction.
    Di Chiara G
    Eur J Pharmacol; 2000 Mar; 393(1-3):295-314. PubMed ID: 10771025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen as a therapy for reducing nicotine withdrawal symptoms.
    Granger RH
    Med Hypotheses; 2005; 65(6):1161-4. PubMed ID: 16002232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.
    Tidey JW; Pacek LR; Koopmeiners JS; Vandrey R; Nardone N; Drobes DJ; Benowitz NL; Dermody SS; Lemieux A; Denlinger RL; Cassidy R; al'Absi M; Hatsukami DK; Donny EC
    Nicotine Tob Res; 2017 Jan; 19(1):59-67. PubMed ID: 27613885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to environmental smoking in never-smoking children: can symptoms of nicotine addiction develop in response to environmental tobacco smoke exposure?
    Schuck K; Kleinjan M; Otten R; Engels RC; DiFranza JR
    J Psychopharmacol; 2013 Jun; 27(6):533-40. PubMed ID: 23139384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine restores monoamine neurotransmitter changes in the cortex and hippocampus of reserpinized rats as a model of depression.
    Khadrawy YA; El-Shamy KA; Mohamed SI
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):863-70. PubMed ID: 21845795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cue reactivity in nicotine and tobacco dependence: a "multiple-action" model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli.
    Chiamulera C
    Brain Res Brain Res Rev; 2005 Feb; 48(1):74-97. PubMed ID: 15708629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.
    Mannucci C; Navarra M; Calzavara E; Caputi AP; Calapai G
    Phytomedicine; 2012 Sep; 19(12):1117-24. PubMed ID: 22921986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking-induced ventral striatum dopamine release.
    Brody AL; Olmstead RE; London ED; Farahi J; Meyer JH; Grossman P; Lee GS; Huang J; Hahn EL; Mandelkern MA
    Am J Psychiatry; 2004 Jul; 161(7):1211-8. PubMed ID: 15229053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
    Nowakowska E; Kus K; Florek E; Czubak A; Jodynis-Liebert J
    Hum Exp Toxicol; 2006 Apr; 25(4):199-209. PubMed ID: 16696296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
    Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.